0141 352 98 55

25 Blythswood Square, Glasgow, G2 4BL

Tracking Covid vaccine progress through Medsmart®
March 3, 2021

In the race against new super spreading virus variants, the UK among other countries have implemented a fast streamed vaccine programme to protect the vulnerable as quickly as possible. Since the beginning of January, 17,916,181 people in the UK have been given their first dose of a COVID-19 vaccine, accounting for around 26% of the population.2,3

As a company with close interaction to patients, we know more than anyone the burden and effect COVID-19 is having on patient populations. Over the course of the pandemic, Talking Medicines have been doing all we can to support our Medsmart® community while sharing data insight that we hope will positively influence patient experience going forwards.

With mass immunisation moving so quickly we were interested in seeing how the results of some of our Medsmart® App features lined up with these government figures.

COVID-19 Tracker

In May 2020 we added the COVID-19 tracker into Medsmart®. This feature was added to allow patients to document their COVID status – whether they suspect that they have COVID, they have had their diagnosis confirmed by a test or are indeed uninfected.

Over the course of the last few months, we have seen steady use of this feature by our Medsmart® community, with an increased number of users confirming their COVID status every week.

COVID-19 Vaccine tracker

At the end of last year, we added an additional feature – our COVID-19 vaccine tracker. This has a similar principle to the COVID-19 tracker, however this version records whether or not Medsmart® users have been vaccinated.

The majority of those using our feature were in the age group of 60-75 years old, with 62% of total participants being male.

We have also been looking at what health conditions users of this feature have. From this analysis we see that the most common conditions are acid reflux, depression, anxiety, high blood pressure and high cholesterol.

Unsurprisingly, many of the medicines being taken match to the common health conditions. We are seeing a high use of Atorvastatin (High cholesterol medicine), Mirtazapine (Depression medicine) and Allopurinol (Gout and Kidney stone medicine).

We believe that the data we collect about coronavirus, patients and vaccines can be used for good. It is important to us that we use our tools not only to connect patients with the wider healthcare system but also to connect the healthcare system back to the patients and their voices. We hope that by continuing to collate and structure data from our COVID-19 trackers, we can continue to contribute to the COVID-19 effort as we continue to strive for a route back to normality.

References:

  1. Man using analytics software on his mac (https://unsplash.com/photos/pypeCEaJeZY)
  2. https://www.bbc.com/news/health-55274833
  3. https://coronavirus.data.gov.uk/details/vaccinations

Recent Blogs

How the pandemic is impacting the way drugs are launched

How the pandemic is impacting the way drugs are launched

Though we don’t yet know to what extent, it is clear the pandemic has had and will continue to have an impact on the pharmaceutical industry and how new drugs are launched. From a pharma perspective, not being able to communicate with healthcare professionals in their...

Softening of public attitude towards COVID-19 vaccines

Softening of public attitude towards COVID-19 vaccines

In December Talking Medicines carried out two ‘pulse’ surveys of the UK public to gauge opinion towards COVID-19 vaccines and found that over the month, attitude had softened, with more people intending to take the vaccine once it becomes available to them. The...

Growing the Product Tech Team

Growing the Product Tech Team

We are so pleased to welcome four talented individuals to our team. Through their knowledge and experience, we look forward to accelerating our AI driven data insights product aligned to the needs of our commercial marketing pharmaceutical customers. Stewart McKee -...